Manulife (Manufacturers Life Insurance)
PEAR

Manulife (Manufacturers Life Insurance)’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,233
Closed -$7.45K – 3127
2023
Q1 		$7.45K Hold
29,233
– – ﹤0.01% 2927
2022
Q4 		$34.5K Buy
+29,233
New +$61.5K ﹤0.01% 2932

Manulife (Manufacturers Life Insurance)'s PEAR Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 29,233 shares — an estimated $7.45K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PEAR in Q4 2022 and held it in 2 quarters. The position peaked at $34.5K in Q4 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 29,233 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $7.45K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
  • Manulife (Manufacturers Life Insurance)'s Pear Therapeutics, Inc. Class A Common Stock position peaked at $34.5K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.